Status:
COMPLETED
Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) occurs secondary to carbohydrate intolerance in pregnancy. Screening of GDM occurs between 24 to 28 weeks gestation by a screening 1-hour 50g glucose challenge test...
Detailed Description
Gestational diabetes mellitus (GDM) occurs secondary to carbohydrate intolerance in pregnancy. Screening of GDM occurs between 24 to 28 weeks gestation by a screening 1-hour 50g glucose challenge test...
Eligibility Criteria
Inclusion
- Singleton pregnancies in women 18 years or older
- Diagnosis of GDM between 24 to 28 weeks gestation
Exclusion
- Preexisting diabetes mellitus or GDM diagnosed prior to 24 weeks by early GDM screening (including patients currently on insulin or any oral hypoglycemic agent)
- Diagnosis of GDM based on fingerstick paneling
- Women who are on chronic steroid therapy
- Multifetal gestation
- Patients with GTT fasting value \>100 (which would indicate a diagnosis of pre-diabetes according to the American Diabetes Association)
- Patients who exhibited poor compliance after the first two weeks of glucose monitoring (which is defined as less than 20% of expected values recorded during the 2 week period of initial testing)
Key Trial Info
Start Date :
April 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04857073
Start Date
April 10 2021
End Date
April 6 2022
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Perinatal Associates
New York, New York, United States, 10019